Cargando…
366. Optimization of a Surrogate Assay for Efficacy of a Malaria Transmission Blocking Vaccine
BACKGROUND: An estimated 241 million malaria cases and 627,000 malaria deaths occurred worldwide in 2020. Efforts to develop a higher efficacy malaria vaccine are a global priority, but parasites pose a complex biological puzzle for vaccine development. Innovative vaccine strategies include transmis...
Autores principales: | Meehan, Cristina, Duffy, Patrick, Renn, Jonathan, Zaidi, Irfan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752217/ http://dx.doi.org/10.1093/ofid/ofac492.444 |
Ejemplares similares
-
Pfs230 yields higher malaria transmission–blocking vaccine activity than Pfs25 in humans but not mice
por: Healy, Sara A., et al.
Publicado: (2021) -
366 soles.
Publicado: (1980) -
The observer's year: 366 nights in the universe
por: Moore, Patrick, et al.
Publicado: (2005) -
Advances in malaria vaccine development: report from the 2017 malaria vaccine symposium
por: Coelho, Camila Henriques, et al.
Publicado: (2017) -
The observer’s year: 366 nights of the universe
por: Moore, Patrick
Publicado: (1998)